Arye Weigensberg
Fortuna: 588 123 $ al 30/06/2026
Fortuna: 588 123 $ al 30/06/2026
Arye Weigensberg currently works at Cronos Group, Inc., as Head-Research & Technology.
Dr. Weigensberg also formerly worked at Altria Israel Ltd, as Chief Executive Officer from 2018 to 2019 and Green Smoke USA, Inc., as Director-Marketing & Brand Management.
Dr. Weigensberg received his undergraduate degree from John Molson School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CRONOS GROUP INC 0,06 % | 10/05/2026 | 211.555 ( 0,06 % ) | 588 123 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CRONOS GROUP INC. | Director Técnico/Científico/I+D | - |
| Empresas | Cargo | Fin |
|---|---|---|
Altria Israel Ltd | Director Ejecutivo | 01/04/2019 |
Green Smoke USA, Inc.
Green Smoke USA, Inc. TobaccoConsumer Non-Durables Manufactures and sells electronic cigarettes | Ventas & Marketing | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Cronos Group, Inc.
Cronos Group, Inc. Pharmaceuticals: OtherHealth Technology Manufactures, cultivates, distributes and retails cannabis products | Health Technology |
John Molson School of Business
John Molson School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Green Smoke USA, Inc.
Green Smoke USA, Inc. TobaccoConsumer Non-Durables Manufactures and sells electronic cigarettes | Consumer Non-Durables |
Altria Israel Ltd | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.